Mitomycin induced pulmonary veno-occlusive disease
Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules.Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with documented lung toxicity as well as PVOD adverse effect...
Main Authors: | Afua Kunadu, J. Stephen Stalls, Heloise Labuschagne, Abdullah Thayyil, Randall Falls, Veeranna Maddipati |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221300712100099X |
Similar Items
-
DIAGNOSTIC SPECIFICS OF PULMONARY VENO-OCCLUSIVE DISEASE
by: E. A. Zhuk, et al.
Published: (2012-06-01) -
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
by: M. Palazzini, et al.
Published: (2009-09-01) -
Pulmonary veno-occlusive disease: Two children with gradual disease progression
by: Ronald W. Day, et al.
Published: (2017-01-01) -
Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?
by: Qin Luo, et al.
Published: (2019-12-01) -
One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease
by: A.C. Barreto, et al.
Published: (2005-02-01)